EDIZAB Trademark

Trademark Overview

On Tuesday, June 12, 2012, a trademark application was filed for EDIZAB with the United States Patent and Trademark Office. The USPTO has given the EDIZAB trademark a serial number of 85649922. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2016. This trademark is owned by Glaxo Group Limited. The EDIZAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
edizab

General Information

Serial Number85649922
Word MarkEDIZAB
Filing DateTuesday, June 12, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "EDIZAB" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, February 8, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 8, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015EXTENSION 5 GRANTED
Monday, June 1, 2015EXTENSION 5 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Friday, December 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 4, 2014EXTENSION 4 GRANTED
Tuesday, December 2, 2014EXTENSION 4 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Thursday, June 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 25, 2014EXTENSION 3 GRANTED
Monday, June 23, 2014EXTENSION 3 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Friday, February 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2014EXTENSION 2 GRANTED
Monday, December 16, 2013EXTENSION 2 FILED
Friday, January 31, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Friday, June 28, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2013EXTENSION 1 GRANTED
Wednesday, June 26, 2013EXTENSION 1 FILED
Wednesday, June 26, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 8, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 11, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 11, 2012ASSIGNED TO LIE
Wednesday, September 26, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 26, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, September 26, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 26, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, September 26, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 26, 2012ASSIGNED TO EXAMINER
Thursday, June 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 15, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

edizab pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological